Aureobasidium mansoni fungal meningitis in a 30-year-old leukemic patient is reported. This is the first reported case of Aureobasidium spp. central nervous system infection. The patient was successfully treated with systemic antifungal chemotherapy with a total dose of 2.2 g of amphotericin B.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000239174DOI Listing

Publication Analysis

Top Keywords

aureobasidium mansoni
8
patient treated
8
mansoni meningitis
4
meningitis leukemia
4
leukemia patient
4
treated amphotericin
4
amphotericin aureobasidium
4
mansoni fungal
4
fungal meningitis
4
meningitis 30-year-old
4

Similar Publications

Prospective study of nosocomial fungal meningitis in children--report of 10 cases.

Scand J Infect Dis

April 1999

Department of Neonatology, 2nd Paediatric Clinic, Old Town University Hospital, Postgraduate Medical School, Bratislava, Czech Republic.

Within an 8-year period, 10 cases of fungal nosocomial meningitis in children 0-13 y old were prospectively identified, 3 caused by yeasts other than Candida spp. (Rhodotorula rubra, Aureobasidium mansoni, Clavispora lusitaniae) and 7 by Candida albicans. Seven patients survived.

View Article and Find Full Text PDF

Five cases of nosocomial meningitis are described that occurred within 5 years in a national cancer center in neutropenic cancer patients after cytotoxic chemotherapy: one caused by the yeast Aureobasidium mansoni and four caused by bacteria (two by Enterococcus faecalis and one by Salmonella enteritis and Arcanobacterium haemolyticus. Despite the severe symptoms, all cases were cured with appropriate antimicrobial therapy.

View Article and Find Full Text PDF

Aureobasidium mansoni fungal meningitis in a 30-year-old leukemic patient is reported. This is the first reported case of Aureobasidium spp. central nervous system infection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!